Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitution Competitive Generic Therapy approval provides 180 days of market exclusivity and further expands Amneal’s differentiated injectables …